Miami Cancer Institute publication analyzes role of tissue-agnostic therapies for the treatment of primary brain tumors
2024-01-19
(Press-News.org) MIAMI, FL – January 19, 2024 – Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
“Novel tissue-agnostic therapeutics targeting driver mutations in tumor cells have been recently approved by the FDA and other regulatory bodies across the world, driven by trials that have demonstrated their efficacy and safety across diverse tumor histology,” said Manmeet S. Ahluwalia, M.D., MBA, FASCO, chief of medical oncology, chief scientific officer, deputy director, and Fernandez Family Foundation Endowed Chair in Cancer Research at Miami Cancer Institute, and first author of the study. “However, the relative rarity of primary brain tumors has limited their representation in early trials of tissue-agnostic medications.”
Basket trials – which test a targeted therapy on the molecular profiles of a broad spectrum of cancers – have recently led to the next frontier of precision medicine, that is tissue-agnostic approvals. These enable the use of targeted therapies based on molecular alterations that are present regardless of the tissue of origin of the tumor. There is a substantial genetic, epigenetic, and immunological heterogeneity of PBTs, which adds to the complexity of the tissue-agnostic therapies. Innate differences between various types of PBTs must be considered carefully because even within the same tumor, multiple subtypes within the same spectrum can exist, adding to the histological heterogeneity. However, the concept of tissue-agnostic therapies evolved in the first place from arguments that common molecular profiles can limit the impact of those inter and intra-tumor heterogeneities from a therapeutic perspective by targeting common molecular alterations.
By gaining a better understanding of tumor biology, several therapeutics with broad efficacy across diverse cancer types have been developed and approved in the last decade. Increasing utilization of next-generation sequencing and biomarker-driven basket trials has helped identify several actionable genetic alterations and their clinical utility. Consequently, this has led to approvals for tissue-agnostic malignancies by the FDA and others, many of which have already demonstrated utility in PBTs.
“However, the limited number of patients with different PBTs in published studies hampers their widespread uptake,” added Ahluwalia. “Therefore, it is becoming increasingly crucial for individuals with primary brain tumors to undergo molecular profiling, enabling the maximization of therapeutic options based on individualized characteristics and for real-world analytics to capture this data. These tissue-agnostic approvals, as the new frontier of precision oncology, hold promise for improved treatment outcomes of gliomas.”
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-01-19
A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder. The study, published in Nature Communications, reveals that a defect in a specific gene (heterozygous variants in the matrix Gla protein, or MGP) may cause a disorder that affects the structure of connective tissues that supports the body.
MGP is a special protein found in blood vessels and cartilage that helps prevent the hardening of these tissues in the body. If MGP is completely missing, it can lead to Keutel syndrome, a rare condition where tissues become calcified, causing issues in the skeleton and blood vessels.
However, in this case, ...
2024-01-19
Infantile epileptic spasms syndrome (IESS), often called infantile spasms, is the most common form of epilepsy seen during infancy. Prompt diagnosis and referral to a neurologist are essential. But research suggests infants are likely to experience delays in referral to a neurologist if their families are from historically marginalized racial/ethnic backgrounds. A new open-access training module for front-line providers from OPENPediatrics, an online learning community launched by Boston Children’s Hospital, aims to change that.
The free, publicly accessible Infantile Spasms curriculum includes short lectures and videos illustrating ...
2024-01-19
In studying social mobility in today’s industrialized nations, researchers typically rely on data from the World Economic Forum or, in the United States, the General Social Survey. But examining the same phenomena from past centuries is a more daunting task because relevant statistics are harder to come by.
However, a social science research team has now discovered a way to examine professional advancement in medieval China (618-907 CE) by drawing from the tomb epitaphs during the Tang Dynasty. These epitaphs contain the ancestral lineages, names, and office titles (e.g., Minister of Personnel, Minister of the Court of Judicial Review, and ...
2024-01-19
BUFFALO, N.Y. – Think of a time when you had two different but similar experiences in a short period. Maybe you attended two holiday parties in the same week or gave two presentations at work. Shortly afterward, you may find yourself confusing the two, but as time goes on that confusion recedes and you are better able to differentiate between these different experiences.
New research published in Nature Neuroscience published on January 19, reveals that this process occurs on a cellular level, findings that are critical to ...
2024-01-19
Recent advances in generative AI help to explain how memories enable us to learn about the world, re-live old experiences and construct totally new experiences for imagination and planning, according to a new study by UCL researchers.
The study, published in Nature Human Behaviour and funded by Wellcome, uses an AI computational model – known as a generative neural network - to simulate how neural networks in the brain learn from and remember a series of events (each one represented by a simple scene).
The ...
2024-01-19
As people age, they gradually lose muscle strength in their arms and legs, making it difficult for them to participate in leisure activities such as hiking and traveling, and they often need to rely on assistive devices such as canes and wheelchairs for mobility. However, these assistive devices do not improve muscle strength, so wearable robots that can compensate for the lack of muscle strength with the help of robots are attracting attention as an innovative technology to improve the health and quality of life of the elderly.
Dr. Lee Jongwon of the Intelligent Robotics Research Center at the Korea Institute of Science and Technology(KIST) ...
2024-01-19
Researchers at the University of Bath have invented a new form of high-performance air purifier that promises zero harmful waste.
Key to the purifier and how it works is FOAM3R filter technology, patented by the University, which is described as a highly adaptable disruptor technology for microbial, CO2 and volatile organic compound (VOC) odour removal.
FOAM3R can be used to produce multi-functional foam structures for a wide range of applications, including aircraft cabins, in-car air filters, ship and boat cabins, residential heating, ventilation and air-conditioning, home air purifiers and respirator and breathing apparatus.
The ...
2024-01-19
Young people are increasingly planning to not have children
Millennials with stronger environmental concerns are less likely to intend to have a child, but this isn’t the case for Gen Z
Lower-income families spend more of their income on childcare than wealthier households
Parents pay an average of £560 a month on childcare – with a quarter paying over £800
A comprehensive new survey reveals the changing face of UK families amid recent economic, social, and political turmoil.
The methodology and initial findings from the UK Generations and Gender Survey are being presented today [Friday 19th January] ...
2024-01-19
While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia (the journal of the European Association of the Study of Diabetes [EASD]) is among the first to show the subsequent impact of remission on cardiovascular outcomes. The study is by Professor Edward Gregg, Head of the School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland, and colleagues.
The new study shows that in patients that took part in the Look ...
2024-01-19
18 January 2024: Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.
For participants in the weight-loss trial who were able to achieve remission i.e. reduce the need for medications and reduce their HbA1c levels (a measure of blood sugar control), the research found there was a 40% lower rate of cardiovascular disease and 33% lower rate of chronic kidney disease in this group.
While previous trials have shown that substantial weight loss using diet and lifestyle can reverse type ...
LAST 30 PRESS RELEASES:
[Press-News.org] Miami Cancer Institute publication analyzes role of tissue-agnostic therapies for the treatment of primary brain tumors
